MetLife Investment Management’s Invacare Corporation IVC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-16,228
Closed -$145K 2342
2020
Q4
$145K Sell
16,228
-1,588
-9% -$13.2K ﹤0.01% 2140
2020
Q3
$134K Hold
17,816
﹤0.01% 2080
2020
Q2
$113K Hold
17,816
﹤0.01% 2198
2020
Q1
$132K Hold
17,816
﹤0.01% 1925
2019
Q4
$161K Hold
17,816
﹤0.01% 2094
2019
Q3
$134K Buy
17,816
+859
+5% +$4.82K ﹤0.01% 2169
2019
Q2
$88K Hold
16,957
﹤0.01% 2390
2019
Q1
$142K Buy
+16,957
New +$122K ﹤0.01% 2167
2018
Q4
Sell
-15,930
Closed -$232K 2608
2018
Q3
$232K Hold
15,930
﹤0.01% 2010
2018
Q2
$296K Hold
15,930
﹤0.01% 1724
2018
Q1
$277K Hold
15,930
﹤0.01% 1724
2017
Q4
$268K Buy
+15,930
New +$259K ﹤0.01% 1767

Other funds holding IVC

MetLife Investment Management's IVC Position: Q1 2021 in Review

MetLife Investment Management sold out of Invacare Corporation (IVC) in Q1 2021, closing a stake of 16,228 shares — an estimated $145K sold.

MetLife Investment Management first reported a position in IVC in Q4 2017 and held it in 12 quarters. The position peaked at $296K in Q2 2018. 135 funds tracked by Wall St. Rank hold IVC as of Q1 2021.

  • MetLife Investment Management reported no remaining Invacare Corporation position as of Q1 2021 after selling out during the quarter.
  • MetLife Investment Management sold 16,228 Invacare Corporation shares in Q1 2021, an estimated $145K.
  • MetLife Investment Management first reported a position in Invacare Corporation in Q4 2017 and held it in 12 quarters.
  • MetLife Investment Management's Invacare Corporation position peaked at $296K in Q2 2018.
  • 135 funds tracked by Wall St. Rank held Invacare Corporation as of Q1 2021.

Based on MetLife Investment Management's 13F filing for Q1 2021, filed 14 May 2021.